The role of toxin A and toxin B in Clostridium difficile infection

Nature

Volumn 467, Issue 7316, 2010, Pages 711-713

  Kuehne, Sarah A ^a   Cartman, Stephen T ^a   Heap, John T ^a   Kelly, Michelle L ^a   Cockayne, Alan ^a   Minton, Nigel P ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLOSTRIDIUM DIFFICILE TOXIN A; CLOSTRIDIUM DIFFICILE TOXIN B;

BACTERIUM; DIARRHEAL DISEASE; DISEASE CONTROL; DISEASE TREATMENT; EXPERIMENTAL STUDY; GENE EXPRESSION; MUTATION; RODENT; SYMPTOM; TOXIN; VIRULENCE;

ARTICLE; BACTERIAL VIRULENCE; CLOSTRIDIUM DIFFICILE INFECTION; CONTROLLED STUDY; CYTOTOXICITY; IN VITRO STUDY; IN VIVO STUDY; MUTANT; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES, NEUTRALIZING; BACTERIAL TOXINS; CERCOPITHECUS AETHIOPS; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; CRICETINAE; DISEASE MODELS, ANIMAL; ENTEROTOXINS; GENE DELETION; HT29 CELLS; HUMANS; NEUTRALIZATION TESTS; VERO CELLS; VIRULENCE;

CLOSTRIDIUM DIFFICILE; CRICETINAE;

EID: 77957988127     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature09397     Document Type: Article

References (26)

1. Poutanen, S. M. & Simor, A. E. Clostridium difficile-associated diarrhea in adults. Can. Med. Assoc. J. 171, 51-58 (2004).
2. Elliott, B. , Chang, B. J. , Golledge, C. L. & Riley, T. V. Clostridium difficile-associated diarrhoea. Intern. Med. J. 37, 561-568 (2007).
3. Lyerly, D. M. , Saum, K. E. , MacDonald, D. K. & Wilkins, T. D. Effects of Clostridium difficile toxins given intragastricallytoanimals. Infect. Immun. 47, 349-352 (1985).
4. Lyras, D. et al. Toxin B is essential for virulence of Clostridium difficile. Nature 458, 1176-1179 (2009).
5. Heap, J. T. , Pennington, O. J. , Cartman, S. T. , Carter, G. P. & Minton, N. P. The ClosTron: auniversal gene knock-out system for the genus Clostridium. J. Microbiol. Methods 70, 452-464 (2007).
6. Heap, J. T. et al. The ClosTron: Mutagenesis inClostridium refined and streamlined. J. Microbiol. Methods 80, 49-55 (2010).
7. Just, I. & Gerhard, R. Large clostridial cytotoxins. Rev. Physiol. Biochem. Pharmacol. 152, 23-47 (2004).
8. Hussain, H. A. , Roberts, A. P. & Mullany, P. Generation of an erythromycin-sensitive derivative of Clostridium difficile strain 630 (630Derm) and demonstration that the conjugativetransposonTn916DE entersthe genomeofthisstrainatmultiplesites. J. Med. Microbiol. 54, 137-141 (2005).
9. Torres, J. , Camorlinga-Ponce, M. &Munoz, O. Sensitivity in culture of epithelial cells from rhesus monkey kidney and human colon carcinoma to toxins A and B from Clostridium difficile. Toxicon 30, 419-426 (1992).
10. Sebaihia, M. et al. The multidrug-resistant human pathogen Clostridium difficile has a highly mobile, mosaic genome. Nature Genet. 38, 779-786 (2006).
11. Hachler, H. , Berger-Bachi, B. & Kayser, F. H. Genetic characterization of a Clostridium difficile erythromycin-clindamycin resistance determinant that is transferable to Staphylococcus aureus. Antimicrob. Agents Chemother. 31, 1039-1045 (1987).
12. O'Connor, J. R. et al. Construction and analysis ofchromosomal Clostridium difficile mutants. Mol. Microbiol. 61, 1335-1351 (2006).
13. Kim, P. H. , Iaconis, J. P. & Rolfe, R. D. Immunization of adult hamsters against Clostridium difficile-associated ileocecitis and transfer of protection to infant hamsters. Infect. Immun. 55, 2984-2992 (1987).
14. Voth, D. E. & Ballard, J. D. Clostridium difficile toxins: mechanism of action and role in disease. Clin. Microbiol. Rev. 18, 247-263 (2005).
15. Du, T. & Alfa, M. J. Translocation of Clostridium difficile toxin B across polarized Caco-2 cell monolayers is enhanced by toxin A. Can. J. Infect. Dis. 15, 83-88 (2004).
16. Chaves-Olarte, E. et al. R-Ras glucosylation and transient RhoA activation determine the cytopathic effect producedbytoxin Bvariants from toxin A-negative strains of Clostridium difficile. J. Biol. Chem. 278, 7956-7963 (2003).
17. Torres, J. F. Purification and characterisation of toxin B from a strain of Clostridium difficile that does not produce toxin A. J. Med. Microbiol. 35, 40-44 (1991).
18. Alfa, M. J. et al. Characterization of a toxin A-negative, toxin B-positive strain of Clostridium difficile responsible for a nosocomial outbreak of Clostridium difficile-associated diarrhea. J. Clin. Microbiol. 38, 2706-2714 (2000).
19. Stabler, R. A. , Dawson, L. F. , Phua, L. T. & Wren, B. W. Comparative analysis of BI/ NAP1/027 hypervirulent strains reveals novel toxin B-encoding gene (tcdB) sequences. J. Med. Microbiol. 57, 771-775 (2008).
20. Drudy, D. , Fanning, S. & Kyne, L. Toxin A-negative, toxin B-positive Clostridium difficile. Int. J. Infect. Dis. 11, 5-10 (2007).
21. Drudy, D. , Harnedy, N. , Fanning, S. , Hannan, M. & Kyne, L. Emergence and control of fluoroquinolone-resistant, toxin A-negative, toxin B-positive Clostridium difficile. Infect. Control Hosp. Epidemiol. 28, 932-940 (2007). (Pubitemid 47218272)
22. Heap, J. T. , Pennington, O. J. , Cartman, S. T. & Minton, N. P. A modular system for Clostridium shuttle plasmids. J. Microbiol. Methods 78, 79-85 (2009).
23. Williams, D. R. , Young, D. I. & Young, M. Conjugative plasmid transfer from Escherichia coli to Clostridium acetobutylicum. J. Gen. Microbiol. 136, 819-826 (1990).
24. Sorg, J. A. & Sonenshein, A. L. Bile salts and glycineas cogerminants for Clostridium difficile spores. J. Bacteriol. 190, 2505-2512 (2008).
25. Cartman, S. T. & Minton, N. P. A mariner-based transposon system for in vivo random mutagenesis of Clostridium difficile. Appl. Environ. Microbiol. 76, 1103-1109 (2010).
26. Sambrook, J. & Russell, D. W. Molecular Cloning: A Laboratory Manual (Cold Spring Harbor Laboratory Press, 2001).